在肺部疾病中分泌的蛋白1
Hongli Liu1, Cristian Coarfa2, Arzoo N Charania1
1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
Metabolites
|June 25, 2025
概括
分泌的蛋白1 (SPP1),或骨质素,在像IPF这样的肺部疾病中是升高的,并且与预后不佳有关. 针对SPP1可能为间歇性肺部疾病提供新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 分泌蛋白1 (SPP1),也称为骨质素 (OPN),是免疫调节,应激反应和组织重塑中的关键蛋白质.
- 在各种间歇性肺病 (ILD) 中,包括异常性肺纤维化 (IPF),SPP1表达升高,并且与预后不佳有关.
- SPP1的作用扩展到传染性肺病,恶性瘤,呼吸道疾病和COVID-19,强调其对呼吸系统健康的广泛影响.
研究的目的:
- 审查SPP1有助于肺部疾病发展的拟议机制.
- 强调SPP1在间歇性肺部疾病 (ILD) 中的作用.
- 突出SPP1作为纤维化肺部疾病的潜在治疗标.
主要方法:
- 对调查肺部疾病中SPP1的研究的文献综述.
- 从单细胞RNA测序和临床研究中分析数据.
- 检查参与纤维生成的各种细胞类型中的SPP1表达.
主要成果:
- 血清,支气管洗液或肺组织中SPP1水平升高通常与肺部疾病的预后不佳相关.
- SPP1在关键的纤维细胞中表达,包括巨细胞,上皮细胞和纤维细胞.
- 最近的单细胞RNA测序数据强调了SPP1在ILD中的重要性.
结论:
- SPP1在各种肺部疾病,特别是ILDs的发病过程中发挥着重要作用.
- 在炎症和组织重塑中SPP1的多方面的功能使其成为纤维化肺部疾病的关键因素.
- SPP1代表了管理和治疗肺部疾病的有希望的治疗标,特别是那些涉及纤维化.
相关概念视频
Phosphoinositides and PIPs
8.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Protein Kinases and Phosphatases
13.5K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.5K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Pneumonia II: Pathophysiology
617
The pathophysiology of pneumonia involves the following steps:
617
Pulmonary Hypertension: Classification and Pathogenesis
297
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
297


